DNMT1 and central nervous system cancer: Similarly, the OrisTM Wound Healing Assay findings revealed that the migration level of glioma cells was greatest in the double-negative control group, least in the NUP37-depleted group, and higher in both DNMT1-overexpressing groups compared to the NUP37-depleted group (Fig. 10A).